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Background
Till not many years ago, the recommended treatment
for advanced laryngeal cancer was a total laryngectomy
followed by adjuvant radiation therapy. Studies con-
ducted from 1980’s have broadened the therapeutic
options, in the attempt to cure the cancer while sparing
laryngeal functions. Functional surgery and a combina-
tion of chemotherapy (CT) and radiotherapy (RT)
appears to be able to reach these objectives. We ana-
lyzed the case series of patients with laryngeal-hypo-
pharyngeal cancer observed in the period 1999-2006 to
evaluate the results on the basis of the treatment
offered, focusing in particular on advanced-stage cancer.
Materials and methods
146 patients were observed, of which 137 were analyzed;
113 patients were operated, while 24 had non-surgical
treatment: 12 of these had a CT-RT protocol with
induction CT followed by concomitant CT-RT.
Results
After surgery in advanced-stage laryngeal cancer survival
was 82% at 18 months, and 36% at 5 years, while after
CT-RT protocol was 60% at 18 months. There was a
statistically relevant advantage in the surgery group
(P=0.02). For what concerns advanced-stage hypophar-
yngeal cancer, survival observed was 60% at 3 years
(48% at 5 years) in the surgery group, and 62% at
3 years in the CT-RT group, without difference at the
log-rank test (P=0.79).
Conclusions
In our case history, surgery had a better outcome than
CT-RT in advanced-stage larynx cancer, even if we
analyzed small groups of patients. These data need to be
confirmed by larger case series; the advancements in
surgery, chemotherapy and radiotherapy have further-
more to be held in due consideration, since they are
opening interesting perspectives in the treatment of
advanced-stage larynx cancer.
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